GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress
Retrieved on:
Mittwoch, Mai 1, 2024
Technology, Medical Devices, Health Technology, Software, Biotechnology, Radiology, Health, Artificial Intelligence, Oncology, Congress, Cancer, Brachy, BMJ, IRT, Spectronic, Electron, GE HealthCare, News, Hospital, Medical journal, Elekta, Research, Catalog, Workflow, Intelligence, Disease, Automation, Patient, Acquisition, RT, MRI, Diagnosis, Revolution, MIM, Medical imaging
Additionally, the company will showcase the newly acquired MIM Software portfolio, as well as other key innovations from GE HealthCare.
Key Points:
- Additionally, the company will showcase the newly acquired MIM Software portfolio, as well as other key innovations from GE HealthCare.
- “At GE HealthCare, we are committed to advancing the frontiers of oncology treatment through AI-driven technologies that transform and optimize the care continuum,” said Dr. Taha Kass-Hout, chief technology and science officer of GE HealthCare.
- At ESTRO 2024, GE HealthCare will also be showcasing the newly updated iRT platform, which was originally launched at ESTRO 2023.
- To learn more about GE HealthCare’s latest innovations within oncology care, please visit the ESTRO 2024 Congress booth #220 in Glasgow from May 3-7 or visit the website here .